Nocion Therapeutics
WALTHAM, MA · Biotechnology, Healthcare · 9 employees
Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons. The company’s platform of unique molecular entities selectively affects inflamed nociceptors. Treatment using this approach aims to provide more durable and robust local analgesic effects while minimizing numbness or paralysis and other systemic off-target effects. The company’s mission is to safe
Funding history
- Funding Round — $23.0M — Mar 2026
- Series SERIES B — $23.0M — Jan 2026
- Funding Round — $31.1M — Mar 2024
- Series series b — $62.0M — Mar 2024
- Funding Round — $7.0M — Aug 2022
Recent signals
- May 27, 2026: Nocion Therapeutics Appoints Vineet Agarwal as Chief Business Officer
- Mar 13, 2026: Raised $23.0M
- Jan 07, 2026: Raised $23.0M in Series SERIES B
- Apr 28, 2025: Nocion Therapeutics Appoints Matthew Frankel as Chief Medical Officer
- Mar 13, 2024: Raised $31.1M
- Mar 04, 2024: Raised $62.0M in Series series b
- Aug 24, 2022: Raised $7.0M
- Aug 31, 2021: Raised $7.0M
See plans & pricing → Track Nocion Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.